TYK Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:2410 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
23 Sep 25	SellHK$160,900	Eric Gu	Individual	10,000	HK$16.09
22 Sep 25	SellHK$319,800	Eric Gu	Individual	20,000	HK$15.99
17 Sep 25	SellHK$63,290,388	TYK Medicines, Inc,ESOP	Company	3,458,000	HK$18.30
16 Sep 25	SellHK$2,667,294	Eric Gu	Individual	140,000	HK$19.05
16 Sep 25	SellHK$2,212,650	Tetranov Pharmaceutical (Zhengzhou) Co., Ltd.	Company	112,500	HK$19.67
16 Sep 25	SellHK$13,666,443	TYK Medicines, Inc,ESOP	Company	696,500	HK$19.67
15 Sep 25	SellHK$289,000	Eric Gu	Individual	20,000	HK$14.45
08 Sep 25	SellHK$302,600	Eric Gu	Individual	20,000	HK$15.13
05 Sep 25	SellHK$307,000	Eric Gu	Individual	20,000	HK$15.35
22 Aug 25	SellHK$2,171,400	Jiangsu Addor Equity Investment Fund Management Co., Ltd.	Company	140,000	HK$15.51
20 Aug 25	SellHK$149,900	Eric Gu	Individual	10,000	HK$14.99

Insider Trading Volume

Insider Buying: 2410 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2410?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	8,010,000	2.11%
Public Companies	17,273,164	4.54%
Employee Share Scheme	27,095,500	7.13%
Institutions	86,746,577	22.8%
Private Companies	99,887,500	26.3%
General Public	141,053,077	37.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 15 shareholders own 62.89% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
26.3%	Tetranov Pharmaceutical (Zhengzhou) Co., Ltd.	99,887,500	HK$1.4b	-0.11%	no data
7.13%	TYK Medicines, Inc,ESOP	27,095,500	HK$366.6m	-13.3%	no data
4.54%	Sichuan Huiyu Pharmaceutical Co., Ltd.	17,273,164	HK$233.7m	0%	no data
4.47%	Changxing Xingchang Industrial Investment Partnership (Limited Partnership)	17,000,000	HK$230.0m	0%	no data
4.07%	Jiangsu Addor Equity Investment Fund Management Co., Ltd.	15,454,500	HK$209.1m	115%	7.32%
3.72%	Ningbo Meishan Bonded Port Area Houji Tongnuo Investment Management Partnership (Limited Partnership	14,146,619	HK$191.4m	0%	no data
2.53%	Jiangsu Addor Capital Results Innovation Venture Capital Fund (Limited Partnership)	9,600,000	HK$129.9m	0%	no data
2.4%	Franklin Templeton Sealand Fund Management Co., Ltd.	9,139,200	HK$123.7m	0%	0.37%
2.28%	Ningbo Meishan Bonded Port Area Houyang Tongchi Investment Management Partnership (Limited Partnersh	8,675,758	HK$117.4m	0%	no data
2.11%	Eric Gu	8,010,000	HK$108.4m	-2.91%	no data
1.21%	Zhuzhou CRRC Times Investment Co., Ltd.	4,608,000	HK$62.3m	0%	23.76%
1.21%	Zhuzhou Guohai Guochuang Qianjin Pharmaceutical Venture Capital Partnership (Limited Partnership)	4,608,000	HK$62.3m	0%	no data
0.87%	Nanjing Addor Equity Investment Management Enterprise (Limited Partnership)	3,300,000	HK$44.6m	-8.33%	3.41%
0.055%	State Street Global Advisors, Inc.	209,500	HK$2.8m	0%	no data
0.0013%	Northern Trust Global Investments	5,000	HK$67.9k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/30 20:41
End of Day Share Price	2025/11/28 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

TYK Medicines, Inc is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Wing-Tai Ng	Deutsche Bank